🔎 Trials Near Me

Home › B-Cell Lymphoma › Ohio › Cleveland

B-Cell Lymphoma clinical trials in Cleveland, OH

9 studies for B-Cell Lymphoma are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

RecruitingPhase 1/2
  • University Hospitals Seidman Cancer Center, Cleveland
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06343311

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

RecruitingPhase 3
  • University Hospitals, Cleveland
  • Cleveland Clinic Foundation, Cleveland
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

RecruitingPhase 1
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07225439

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

RecruitingPhase 1
  • Clinical Trial Site, Cleveland
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06393738

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RecruitingPhase 1/2
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

RecruitingPhase 3
  • Cleveland Clinical Taussig Cancer Center, Cleveland
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Rainbow Babies, Cleveland
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

RecruitingPhase 1
  • University Hospitals Seidman Cancer Center, Cleveland
  • Taussig Cancer Institute | Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Oct 21, 2024 · NCT05312801

B-Cell Lymphoma trials in other cities

Other studies in Cleveland

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.